Cogent Biosciences, Inc. (COGT) Free cash flow 2017–2025
Cogent Biosciences, Inc. (COGT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$266.0MFY2025 · since FY2017: -$26.7M → -$266.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$266.0M | -27.7% |
| FY2024 | -$208.4M | -33.2% |
| FY2023 | -$156.4M | -24.6% |
| FY2022 | -$125.5M | -107.5% |
| FY2021 | -$60.5M | — |
| FY2019 | -$41.5M | -25.8% |
| FY2018 | -$33.0M | -23.5% |
| FY2017 | -$26.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice